Vir Biotechnology Inc (VIR)
7.18
+0.23
(+3.31%)
USD |
NASDAQ |
Nov 22, 11:05
Vir Biotechnology Total Assets (Quarterly): 1.498B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.498B |
| June 30, 2024 | 1.670B |
| March 31, 2024 | 1.794B |
| December 31, 2023 | 1.919B |
| September 30, 2023 | 2.045B |
| June 30, 2023 | 2.244B |
| March 31, 2023 | 2.666B |
| December 31, 2022 | 2.802B |
| September 30, 2022 | 2.696B |
| June 30, 2022 | 2.619B |
| March 31, 2022 | 2.887B |
| December 31, 2021 | 1.954B |
| Date | Value |
|---|---|
| September 30, 2021 | 1.210B |
| June 30, 2021 | 1.058B |
| March 31, 2021 | 1.136B |
| December 31, 2020 | 918.76M |
| September 30, 2020 | 943.26M |
| June 30, 2020 | 672.24M |
| March 31, 2020 | 477.11M |
| December 31, 2019 | 512.07M |
| September 30, 2019 | 422.64M |
| June 30, 2019 | 456.85M |
| December 31, 2018 | 191.60M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
477.11M
Minimum
Mar 2020
2.887B
Maximum
Mar 2022
1.686B
Average
1.732B
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc | 219.48B |
| Biomarin Pharmaceutical Inc | 6.851B |
| Arbutus Biopharma Corp | 140.44M |
| GlycoMimetics Inc | 15.70M |
| FibroGen Inc | 264.42M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 257.63M |
| Shareholders Equity (Quarterly) | 1.241B |
| Current Ratio | 8.938 |